Medikinet® tablets can be used as part of a comprehensive treatment programme for attention deficit hyperactivity disorder (ADHD) in children aged 6 years of age and over when remedial measures alone have proved insufficient. 1 Medikinet tablets are not licensed for use in adults 18yrs and over.
For full safety and monitoring information please refer to section 4 of the SmPC or click here.
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare Professionals are asked to report any suspected adverse reactions.
EXTERNAL LINK
You are now leaving the Medice UK website and are being directed to a website that contains information about Medice products, but which is not owned by Medice UK.
Please confirm you wish to follow this link.